Master Manufacturing Record (21 CFR 111.210)
The Master Manufacturing Record under 21 CFR 111.205 / 111.210 is the dietary-supplement-specific MMR — the controlled, approved blueprint that defines exactly how one unique formulation at one specific batch size will be manufactured, packaged, and labelled.
Read the full summary
Subtly but importantly different from the drug MMR under 21 CFR 211.186: a separate MMR is required for each unique batch size, two-person approval is explicit, and the content list maps directly into Part 111's identity-purity-strength-composition specification framework.
On this page · 8 sections
How does Master Manufacturing Record (21 CFR 111.210) apply to your shop floor?
Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.
01What the Part 111 MMR is
21 CFR 111.205 requires the supplement manufacturer to prepare and follow a written Master Manufacturing Record (MMR) for each unique formulation of dietary supplement that is manufactured, and for each batch size. The MMR is the controlled blueprint — the document that defines exactly what materials at what amounts, in what sequence, on what equipment, under what controls, will produce a single batch of one specific finished supplement at one specific batch size.
111.205(b) is explicit: 'You must establish a master manufacturing record for each unique formulation of dietary supplement that you manufacture, and for each batch size, to ensure uniformity in the finished batch from batch to batch.' Changing the batch size — even with the same formula — triggers a separate MMR. This is one of the most-cited 483 observations on supplement contract manufacturers who scale a formula up or down without re-issuing the MMR.
02Content elements required by 111.210
21 CFR 111.210 enumerates the required content of the MMR — twelve elements:
- 111.210(a) — Identity of the finished dietary supplement: name, strength, concentration, weight, or measure.
- 111.210(b) — Quantity to be made: planned batch size.
- 111.210(c) — Complete list of components to be used (including dietary ingredients and other ingredients) with the established specification for each.
- 111.210(d) — Accurate statement of the weight or measure of each component to be used.
- 111.210(e) — Identity and weight or measure of each dietary ingredient that will be declared on the Supplement Facts panel and the percent of overage decided by quality control personnel to compensate for the loss of activity of the dietary ingredient during manufacture or expected shelf life of finished batch.
- 111.210(f) — Statement of any intentional overage amount of a dietary ingredient.
- 111.210(g) — Statement of the theoretical yield of a manufactured dietary supplement expected at each point, step, or stage of the manufacturing process where control is needed to ensure the quality of the dietary supplement, and the expected yield when you finish manufacturing the dietary supplement, including the maximum and minimum percentages of theoretical yield beyond which a deviation investigation of a batch is necessary and material review is conducted and disposition decision is made.
- 111.210(h) — Description of packaging and a representative label or graphic representation of the label.
- 111.210(i) — Written instructions, including specifications for each point, step, or stage in the manufacturing process where control is necessary to ensure the quality of the dietary supplement and that the dietary supplement is packaged and labelled as specified in the master manufacturing record.
- 111.210(j) — Procedures for sampling and a cross-reference to procedures for tests or examinations.
- 111.210(k) — Specific actions necessary to perform and verify points, steps, or stages in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.
- 111.210(l) — A corresponding cross-reference to any standard operating procedure (SOP) referenced in the MMR.
03Two-person approval (111.205(c))
111.205(c) requires that the MMR be prepared by a qualified individual and reviewed, approved, and signed/dated by quality control personnel. In effect this is a two-person rule: the preparer (typically a formulator, R&D scientist, or production engineer) and the independent QC approver (cannot be the same person and must be from the independent Quality Control unit established under 111.105). Both signatures must be on the MMR before it can be used to manufacture a batch.
04Revisions and change control
Once approved, the MMR is immutable. Any change — a supplier swap on a component, a re-formulation, an equipment change that alters process parameters, a batch-size change, a label artwork revision that changes a declared amount — triggers a new revision. The mechanics:
- Issue a new MMR revision (v2, v3…) with revision number, effective date, and rationale.
- Two-person prepare/approve cycle repeats for every revision.
- Historical MMR revisions are retained for the same period as the BPRs made under them — 1 year past the dietary supplement's shelf-life expiration date under 111.605.
- BPRs reference the specific MMR revision used for that batch.
- Old MMRs are 'OBSOLETE' watermarked to prevent accidental reuse.
05MMR vs BPR — the relationship
The Master Manufacturing Record is the controlled blueprint. The Batch Production Record (BPR) under 111.260 is the per-batch reproduction of the MMR with actual data filled in — actual component lot numbers, actual weighed amounts, actual times, actual operator e-signatures, actual yields, actual test results. 111.255 makes the relationship explicit: 'You must prepare a batch production record every time you manufacture a batch of a dietary supplement … by following the instructions in the master manufacturing record.' One MMR; many BPRs over its life.
| Aspect | MMR (111.205-111.210) | BPR (111.255-111.260) |
|---|---|---|
| Frequency | One per unique formulation × batch size | One per batch |
| Mutable? | No — immutable once approved; revisions are new versions | Filled-in execution record |
| Approval | Two-person (preparer + QC) | Multiple e-sigs at each step + QC release |
| Retention | Retained 1 year past shelf life of all batches made under it | Retained 1 year past the specific batch's shelf life |
06MMR under Part 111 vs Part 211 — the supplement-specific differences
The drug-MMR rule is 21 CFR 211.186; the supplement-MMR rule is 21 CFR 111.205 / 111.210. Differences that operational teams trip on when moving between drug and supplement work:
| Aspect | Part 211 (drugs) | Part 111 (supplements) |
|---|---|---|
| Separate MMR per batch size | Common practice but not statutorily explicit | Statutorily required (111.205(b)) |
| Two-person approval | 211.186 says 'prepared, dated, and signed by one person and independently checked, dated, and signed by a second person' | 111.205(c) says 'prepared, dated, and signed/dated by a qualified person … and reviewed, approved, and signed/dated by quality control personnel' |
| Overage on label-claim ingredients | Standard practice, documented in MMR | Explicitly enumerated in 111.210(e) as required content |
| Theoretical yield with action limits | 211.103 requires reconciliation; 211.186 requires theoretical yield | 111.210(g) requires theoretical yield AND maximum/minimum percentages triggering deviation investigation |
| Cross-reference to component specifications | Implicit | Explicit in 111.210(c) |
07Five 483-pattern failures
- Manufacturing at a batch size that does not match any approved MMR — the most common single supplement 483 in 2022-2024 FDA inspection trends.
- MMR signed only by the preparer (no independent QC signature) — automatic finding.
- Overage rationale missing or not approved by QC — 111.210(e) requires QC to set the overage.
- Theoretical yield without action limits — 111.210(g) requires the maximum/minimum that triggers deviation investigation.
- BPRs referencing an obsolete MMR revision because the change-control process did not propagate the new MMR to the production floor.
08How V5 Ultimate handles the Part 111 MMR
- mmr table keyed by (formula_id, batch_size); revision is monotonically incremented; two e-sigs (preparer + independent QC) required before status = approved.
- Overage values stored per ingredient with QC-set rationale; changing the overage = new MMR revision.
- Theoretical yield + action-band lower/upper enforced at end-of-batch; exceeding triggers automatic NCR.
- Work-order release embeds the full MMR into work_orders.mmr_snapshot (jsonb) so reports render off the snapshot, not the live MMR.
- Obsolete revisions are watermarked OBSOLETE on every regenerated PDF.
- /app/reports → 'MMR with revision history' renders the full audit chain.
Frequently asked questions
Q.Do I need a separate MMR for every batch size?+
Yes. 21 CFR 111.205(b) requires a separate MMR for each unique formulation AND for each batch size. Scaling a formula from 100 kg to 500 kg requires a new MMR.
Q.Who must sign the MMR?+
Two people. The preparer (a qualified person) and the independent QC approver (from the QC unit established under 111.105). Both signatures with dates are required before the MMR is usable.
Q.Can the MMR reference SOPs instead of repeating their content?+
Yes. 111.210(l) explicitly contemplates cross-references to SOPs. The SOPs themselves must be controlled documents.
Q.How long must I retain a superseded MMR?+
At least 1 year past the shelf-life expiration date of the LAST batch manufactured under it (111.605). In practice, retain the entire history — it is cheap and the regulatory cost of misplacing it is high.
Q.Is the MMR the same as a 'recipe' or 'formula'?+
No. The formula is a list of ingredients and amounts. The MMR includes the formula plus equipment, procedures, in-process controls, sampling plans, theoretical yields, action limits, label representation, and QC tests. It is a far broader controlled document.
Q.What if a customer asks me to do a one-off batch at a new batch size?+
You cannot run it until you have issued and approved a new MMR for that batch size. A 'one-off' is not an exemption — 111.205(b) does not contemplate it.
Q.Does the MMR include the Supplement Facts panel?+
Yes — 111.210(h) requires 'a description of packaging and a representative label or graphic representation of the label,' which includes the Supplement Facts panel and the structure/function claim text.
Primary sources
- 21 CFR 111.205 — Requirement to establish a master manufacturing record
- 21 CFR 111.210 — What the master manufacturing record must include
- 21 CFR 111.260 — Batch production record (BPR) content
- FDA Final Rule — Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements (72 FR 34751, 2007)
- FDA Small Entity Compliance Guide — Part 111 cGMP for Dietary Supplements (2010)
Further reading
- MMR (umbrella entry)How the supplement MMR fits alongside the drug Part 211 MMR.
- 21 CFR Part 111The full supplement cGMP framework the MMR sits inside.
- Batch Production RecordThe per-batch reproduction of the MMR with actual data.
- Finished product specs (111.70(e))The specification target the MMR is designed to deliver.
- Identity testing (111.75)Per-lot identity that gates every component charge the MMR commands.
- QC unit (111.105)The independent function that approves and revises the MMR.
Want to see how Master Manufacturing Record (21 CFR 111.210) could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.